EMN
55
-4
PNC
55
-6
NTAP
43
-2
DVN
29
-3
ORCL
60
2
XOM
57
-3
PG
33
-2
IP
60
-5
ES
47
-2
MMC
47
-6
CF
59
-4
MO
42
3
ALLE
30
-5
CSCO
54
-3
NAVI
46
-4
GILD
49
-3
GD
52
-4
CVX
34
-3
MHK
49
-7
ICE
49
-6
EMN
55
-4
PNC
55
-6
NTAP
43
-2
DVN
29
-3
ORCL
60
2
XOM
57
-3
PG
33
-2
IP
60
-5
ES
47
-2
MMC
47
-6
CF
59
-4
MO
42
3
ALLE
30
-5
CSCO
54
-3
NAVI
46
-4
GILD
49
-3
GD
52
-4
CVX
34
-3
MHK
49
-7
ICE
49
-6
Financhill
Back

SPDR S&P Bank ETF Vs. Sarepta Therapeutics Industry Stock Comparison

Buy
53

KBE
SPDR S&P Bank ETF

Last Price:
$56.85
Seasonality Move:
2.35%
Sell
43

SRPT
Sarepta Therapeutics

Last Price:
$18.22
Seasonality Move:
37.39%
Buy
53
SPDR S&P Bank ETF (KBE) is a Buy

Is SPDR S&P Bank ETF a Buy, Sell or Hold?

  • The current SPDR S&P Bank ETF [KBE] share price is $56.92. The Score for KBE is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
  • KBE is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $18.21. The Score for SRPT is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

KBE Stock Price Chart

What is SPDR S&P Bank ETF's stock price today?

  • The SPDR S&P Bank ETF share price today is $56.92
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KBE is experiencing selling pressure, which indicates risk of future bearish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $18.21
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

KBE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 15.27 Buy
Relative Strength Index (14 RSI): 54.34 Buy
Chaikin Money Flow: -2433046 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (53.7 - 57.96) Buy
Bollinger Bands (100): (50.25 - 56.51) Buy

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.92 Buy
Relative Strength Index (14 RSI): 31.01 Sell
Chaikin Money Flow: -3874242 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (14.77 - 30.41) Sell
Bollinger Bands (100): (25.74 - 82.82) Sell

KBE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 58.29 Sell
20-day SMA: 56.25 Buy
50-day SMA: 54.67 Buy
200-day SMA: 55.16 Buy
8-day EMA: 45.21 Buy
20-day EMA: 26.26 Buy
50-day EMA: 12.42 Buy
200-day EMA: 3.39 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 18.58 Sell
20-day SMA: 18.73 Sell
50-day SMA: 31.46 Sell
200-day SMA: 87.68 Sell
8-day EMA: 14.59 Buy
20-day EMA: 8.49 Buy
50-day EMA: 4.02 Buy
200-day EMA: 1.1 Buy

SPDR S&P Bank ETF Earnings Growth & KBE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.02 per share, an increase next quarter of $0.77 per share, a decrease this year of $5.77 per share, and an increase next year of $5.30 per share.

SPDR S&P Bank ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):